Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China

被引:0
作者
Qianqian Zhang
Zheng Wang
Yanping Lv
Jiang Zhao
Qiang Dang
Dongfeng Xu
Dongxiang Zhao
Haiyang Liu
Ziqi Wang
Xingru Zhao
Zhiwei Xu
Xiaoju Zhang
机构
[1] Zhengzhou University People’s Hospital,Department of Respiratory and Critical Care Medicine
[2] Henan Provincial People’s Hospital,Department of Respiratory and Critical Care Medicine
[3] Zhoukou Central Hospital,Department of Respiratory and Critical Care Medicine
[4] Nanyang Central Hospital,Department of Respiratory and Critical Care Medicine
[5] The First Affiliated Hospital of Nanyang Medical College,Department of Respiratory and Critical Care Medicine
[6] Dengzhou Central Hospital,Clinical Research Service Center
[7] Henan Provincial People’s Hospital,undefined
[8] Zhengzhou University People’s Hospital,undefined
来源
Human Cell | 2021年 / 34卷
关键词
COVID-19; SARS-CoV-2; Ground glass opacity; Lymphopenia; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
Since December 2019, the novel coronavirus SARS-CoV-2 pandemic (COVID-19) outbroke in Wuhan and spread in China. Here we aimed to investigate the clinical and radiological characteristics of COVID-19 cases. We collected and analyzed the clinical data of 172 hospitalized cases of COVID-19 who were diagnosed via qRT-PCR of nasopharyngeal swabs during January 2020 and February 2020. The chest images were reviewed by radiologists and respirologists. The older patients with COVID-19 in Henan Province had more severe disease and worse prognosis. The male sex, smoking history and Wuhan exposure of patients are not related to the severity or prognosis of COVID-19. Family gatherings were showed among 26.7% of patients. A greater proportion of patients in the severe group suffer from combined chronic diseases. CT results showed that most patients had bilateral lung lesions and multiple lung lobes. The lungs of severe patients are more damaged. Both the infection range and inflammatory factor levels are related to the poor prognosis. Antiviral drugs, immunoglobulin and traditional Chinese medicine are mainly used for the treatment of COVID-19 patients. The discharge rate of COVID-19 patients was 93.0%, and the mortality rate was 2.3%. Case type, lymphocyte ratio grade, and respiratory failure at admission are risk factors for poor prognosis, except for the number of infiltrating lung lobes. The results showed that severe disease process, lymphopenia and respiratory failure are risk factors for the COVID-19.
引用
收藏
页码:419 / 435
页数:16
相关论文
共 148 条
  • [61] Yang J(undefined)undefined undefined undefined undefined-undefined
  • [62] Zou L(undefined)undefined undefined undefined undefined-undefined
  • [63] Ruan F(undefined)undefined undefined undefined undefined-undefined
  • [64] Huang M(undefined)undefined undefined undefined undefined-undefined
  • [65] Liang L(undefined)undefined undefined undefined undefined-undefined
  • [66] Huang H(undefined)undefined undefined undefined undefined-undefined
  • [67] Hong Z(undefined)undefined undefined undefined undefined-undefined
  • [68] Yang X(undefined)undefined undefined undefined undefined-undefined
  • [69] Yu Y(undefined)undefined undefined undefined undefined-undefined
  • [70] Xu J(undefined)undefined undefined undefined undefined-undefined